InsiderTrades

Form 4 for STOK Stoke Therapeutics, Inc.

Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001415889-25-008359 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-18 2025-03-15 STOK Ticho Barry Chief MEDICAL Off M - OptEx $0.00 +23.1K 57.8K +66% $0
DM 2025-03-18 2025-03-15 STOK Ticho Barry Chief MEDICAL Off M - OptEx $0.00 -23.1K 30.0K -44% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-15 M A 10,000 $0.00 67,846 D — —
2 Common Common Stock 2025-03-15 M A 13,100 $0.00 57,846 D — —
3 Derivative Restricted Stock Units 2025-03-15 M D 13,100 $0.00 26,200 D — · — to 2027-03-15 13,100 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F2) The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date.
4 Derivative Restricted Stock Units 2025-03-15 M D 10,000 $0.00 30,000 D — · — to 2028-03-15 10,000 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F3) The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date.